Antibodies binding preferentially human CSF1R extracellular domain 4 and their use

Details for Australian Patent Application No. 2010329934 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Lanzendoerfer, Martin; Dimoudis, Nikolaos; Fertig, Georg; Fidler, Alexander; Kaluza, Klaus; Pickl, Marlene; Ries, Carola; Seeber, Stefan

Agent Griffith Hack

Pub. Number AU-A-2010329934

PCT Pub. Number WO2011/070024

Priority 10173407.7 19.08.10 EP; 09015310.7 10.12.09 EP

Filing date 7 December 2010

Wipo publication date 16 June 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

17 May 2012 PCT application entered the National Phase

  PCT publication WO2011/070024 Priority application(s): WO2011/070024

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010329940-Heterocyclic sulfonamide derivatives

2010329930-Tire bead for heavy civil engineering vehicle